Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Buzz on the Bullboards: More tricks or treats this investing season?

Hallowe’en is always a spooky season, between next week’s U.S. election, the spreading battles across the globe, and the cost of living … there is plenty to be scared about. Even so, your stock portfolio need not be one of those things. ...

Revolutionizing immunotherapies with groundbreaking DPX platform

The following is a transcription of the above video, and The Market Online has edited it for clarity . BioVaxys Technology Corp (CSE:BIOV) is a Canadian-based clinical stage biopharmaceutical company focused on improving patient lives with novel immunotherapies. CE...

Buzz on the Bullboards: 3 stocks breaking the silence of a quiet June

“Sell in May and go away” is a theme investors and stock traders know well, and during this quieter month of June ahead of summer, some public Canadian companies have been engaging in serious business. This week, we saw the TSX hit a one-month ...

Silver price predictions: Is the 2024 gold and silver rally just starting?

By Rob Driscoll Like birds of a feather, gold and silver have historically flocked together, and the two precious metal mates have certainly found their wings in 2024. Gold hit an all-time high in April, and silver parroted the move by breaching the $29 mark l...

Buzz on the Bullboards: Stocks Making the Most of the Fall Season

Following news that it expects revenue for Q3 2021 to be at least $8 million, resulting in total revenue for the nine months ended September 30, 2021 of at least $22 million (twice as much as that period, last year), PyroGenesis Canada Inc. ( TSX-V.PYR , Forum ) announ...

Another Climb of the S&P 500 Wall of Worry Approaching?

Monday's session brought us the anticipated downside, but stocks reversed to close solidly higher. Has this been it, and the train is ready to leave the station now? The overnight dip shows it might not be a foregone conclusion, but let's take it step-by-step. S&P 500 in t...

Should Gold Bulls Celebrate the Persistent ZIRP?

Yesterday, the Fed issued the statement from the FOMC meeting on June 9-10. The statement is little changed from the April edition. Nevertheless, there are two important differences. First, the members of the Committee have acknowledged the improvement in the economic si...

Will Great Unlock Push Gold Prices Down?

As Great Lockdown was positive for the gold prices, the Great Unlock will be bad, right? We invite you to read our today’s article about the Great Unlock and find out whether it really must be negative for the gold prices. It’s all governme...

Technical Analyst: Gold Explorer Stock at Point of Breakout After Prolonged Major Accumulation

Technical analyst Clive Maund charts Black Tusk Resources and explains why he sees it as an "immediate strong speculative buy." If you are one of those people who likes to show up at a lavish party right at the starting bell, after weeks or even months of arduous p...

Small-Cap Pharma Fast-Tracking Repurposed Drug for Covid-19

Algernon Pharmaceuticals is quickly moving ahead with a multinational Phase 2b/3 trial for Ifenprodil. Algernon Pharmaceuticals Inc. (AGN:CSE; AGNPF:OTCQB; AGW:FSE) , a Canada-based clinical stage drug development company that focuses on drug repurposing, believes ...
1 2 3 4